NEWTON, Mass.--(BUSINESS WIRE)-- Clinical Data, Inc. (NASDAQ: CLDA) today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the 29th Annual J.P. Morgan Healthcare Conference. Clinical Data's presentation will take place at 4:30 p.m. PST on Wednesday, January 12, 2011 at The Westin St. Francis hotel, San Francisco, CA.
A live audio and archived webcast of the presentation will be accessible through Clinical Data's website at www.clda.com.
About Clinical Data, Inc.
Clinical Data’s mission is to develop first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in major therapeutic areas including oncology and inflammatory diseases. To learn more, please visit the Company's website at www.clda.com.
Clinical Data, Inc.
Theresa McNeely, 617-467-6673
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Health Biotechnology Cardiology Pharmaceutical